GNCC Capital, Inc., operating through its subsidiary BioCann Pharma S.A.S., specializes in the production and marketing of pharmaceutical-grade CBD oils derived from cannabis. These products are distributed via established networks throughout Colombia and across the broader Latin American market. The parent company's headquarters are located in Las Vegas, Nevada.